Table 1.
Group I CRL (cm) (1.4–3.6) 30–60 days | Group II CRL (cm) (4.5–7.2) 67–90 days | Group III CRL (cm) (8–19) 97–135 days | Group IV CRL (cm) (21–33) 142–191 days | Group V CRL (cm) (36–40) 205–235 days | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
E | LP-S | TM | S | E | LP-S | TM | S | E | LP-S | TM | S | E | LP-S | TM | S | E | LP-S | TM | S | |
NNE | – | – | – | – | – | – | – | – | – | + | + | – | – | ++ | ++ | – | – | ++ | ++ | – |
GFAP | – | – | – | – | – | – | – | – | – | – | – | – | – | ++ | ++ | ++ | – | ++ | ++ | ++ |
VIM | – | – | – | – | – | + | + | + | ++ | ++ | ++ | ++ | – | ++ | ++ | ++ | – | +++ | +++ | +++ |
VIP | – | – | – | – | – | – | – | – | – | – | – | – | + | – | – | – | ++ | – | – | – |
NPY | – | – | – | – | – | – | – | – | – | – | – | + | – | – | – | +++ | – | – | – |
–, No immunoreactivity; +, low immunoreactivity; ++, moderate immunoreactivity; +++, high immunoreactivity.E = epithelium; LP-S = lamina propria-submucosa; T = tunica muscularis; S = serosa.